ALVOTECH AND ADVANZ PHARMA ANNOUNCE FIRST KNOWN REGULATORY SUBMISSION WORLDWIDE FOR PROPOSED BIOSIMILAR TO EYLEA® 8 MG

Reuters · 1d ago

Please log in to view news